HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TAKEDA-143242 increased survival via reduced cytokines in porcine peritonitis.

Abstract
TAKEDA-143242 (TAK-242) is a small molecule shown to inhibit lipopolysaccharide-induced intracellular signaling and inflammation. In vitro studies demonstrated that TAK-242 can prevent release of TNF-α, IL-1β, and IL-6 from activated macrophages of several species, including pigs. This study tested the hypothesis that TAK-242 would protect pigs from lethal gram-negative peritonitis via an anti-cytokine mechanism. A validated model of porcine gram-negative peritonitis, which employs chronically inplantated cardiac transducers and aortic and pulmonary artery catheters, was used. Pigs were pretreated with TAK-242 or its vehicle via a blinding procedure prior to intraperitoneal implantation of an LD(90) dose of E. coli 0111:B4 in a fibrin clot. Ten pigs were treated with TAK-242 and nine with its vehicle. All ten TAK-242 treated pigs survived, while three of the nine vehicle treated pigs survived (P = 0.01 χ(2) test). Pulmonary artery pressure increased markedly in vehicle pigs, and this elevation was significantly (two-way ANOVA) obviated in TAK-242 treated group. Circulating levels of cytokines in vehicle treated pigs showed increased expression (3930 ± 1770 at 1 h, 1007 ± 400 TNF-α at 2 h; 719 ± 308 of IL-1β at 2-6 h; 33000 ± 1000 of IL-6 at 2-4 h [pg/mL, mean ± SEM]). Peak circulating levels of these cytokines were significantly reduced by pretreatment with TAK-242 (<25 pg/mL TNF-α ; <100 pg/mL IL-1β; 0-1700 pg/mL IL-6, peak values). This study found that pretreatment with TAK-242 yielded significantly positive survival benefit in a lethal sepsis model that was associated with improved cardiovascular status and suppressed cytokine release.
AuthorsRoy D Goldfarb, John W Ortegel, Joseph E Parrillo, Sergio Zanotti-Cavazzoni, Larry C Casey, R Phillip Dellinger
JournalThe Journal of surgical research (J Surg Res) Vol. 166 Issue 2 Pg. e165-73 (Apr 2011) ISSN: 1095-8673 [Electronic] United States
PMID21236445 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Infective Agents, Local
  • Cytokines
  • Interleukin-1beta
  • Interleukin-6
  • Sulfonamides
  • Toll-Like Receptor 4
  • Tumor Necrosis Factor-alpha
  • ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate
Topics
  • Animals
  • Anti-Infective Agents, Local (pharmacology)
  • Cytokines (blood)
  • Disease Models, Animal
  • Escherichia coli Infections (drug therapy, immunology, mortality)
  • Heart (physiology)
  • Interleukin-1beta (blood)
  • Interleukin-6 (blood)
  • Kaplan-Meier Estimate
  • Macrophages (drug effects, immunology, metabolism)
  • Peritonitis (drug therapy, immunology, mortality)
  • Sepsis (drug therapy, immunology, mortality)
  • Sulfonamides (pharmacology)
  • Sus scrofa
  • Toll-Like Receptor 4 (metabolism)
  • Tumor Necrosis Factor-alpha (blood)
  • Vascular Resistance (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: